Almotriptan Malate

• CAT Number: A001177
• CAS Number: 181183-52-8
• Molecular Formula: C17H25N3O2S.C4H6O5
• Molecular Weight: 469.55
• Purity: ≥95%
• Synonyms: LAS 31416
• Target: Neuronal Signaling
• Solubility: >16.7mg/mL in DMSO
• Storage: 3 years -20C powder
• IUPAC Name: N,N-dimethyl-2-[5-(pyrrolidin-1-ylsulfonylmethyl)-1H-indol-3-yl]ethanamine;2-hydroxybutanedioic acid
• InChI: InChI=1S/C17H25N3O2S.C4H6O5/c1-19(2)10-7-15-12-18-17-6-5-14(11-16(15)17)13-23(21,22)20-8-3-4-9-20;5-2(4(8)9)1-3(6)7/h5-6,11-12,18H,3-4,7-10,13H2,1-2H3;2,5H,1H2,(H,6,7)(H,8,9)
• InChIKey: QHATUKWEVNMHRY-UHFFFAOYSA-N
• SMILES: CN(C)CCC1=CNC2=C1C=C(C=C2)CS(=O)(=O)N3CCCC3.C(C(C(=O)O)O)C(=O)O

Almotriptan Malate（Cat No.:A001177）is a selective serotonin receptor agonist used to treat acute migraine attacks in adults. By stimulating 5-HT1B/1D receptors, it constricts dilated blood vessels in the brain, alleviating migraine symptoms such as headache, nausea, and sensitivity to light and sound. Known for its rapid onset of action and good tolerability, almotriptan malate provides effective relief from moderate to severe migraines. High-purity almotriptan malate ensures consistent therapeutic outcomes, making it a reliable option for migraine management in clinical and pharmaceutical settings.